Erschienen in:
01.06.2010 | Review Article
Adverse Effects of Biological Agents in the Treatment of Psoriasis
verfasst von:
Franco Rongioletti, Martina Burlando, Aurora Parodi
Erschienen in:
American Journal of Clinical Dermatology
|
Sonderheft 1/2010
Einloggen, um Zugang zu erhalten
Abstract
Tumour necrosis factor (TNF) antagonists are generally well tolerated, but carry the risk of side effects. In patients with psoriasis, the potential risks with anti-TNF agents may be overestimated because the most commonly reported adverse events are based on studies in patients with rheumatoid arthritis or inflammatory bowel disease. Whereas patients with psoriasis typically receive monotherapy, these patients are treated with biological-based combination therapies. Furthermore, patients with psoriasis have distinctive and different comorbidities, which could play a role in the development of different adverse events. However, the potential risks of the use of biological agents should always be taken into consideration